Jason Hurt
CEO
Dr. Jason Hurt is a seasoned clinician-scientist and entrepreneur with deep expertise in radiopharmaceutical development, clinical trial strategy, and oncology drug development. In March 2025, he founded Theragnostic Insights, a consulting and strategic advisory firm dedicated to advancing theranostic solutions and radioligand therapies.
111
Sept. 11, 2025
Jason Hurt, Founder & CEO of Theragnostic Insights
In this episode, we are joined by Dr. Jason Hurt, a clinician-scientist and entrepreneur with extensive experience in radiopharmaceutical development, clinical trial strategy, and oncology drug development. In March 2025, Dr. Hurt founded Theragnostic Insights, a consulting and strategic advisory firm focused on advancing theranostic solutions and radioligand therapies—pioneering approaches that are shaping the future of cancer treatment.
Guest: Jason Hurt